Survey of Twitter Viewpoint on Application of Drugs by VADER Sentiment Analysis among Distinct Countries

Author:

Bose Rajesh1,Aithal P. S.2,Roy Sandip3

Affiliation:

1. Post-Doctoral Research Fellow, Srinivas University, Mangalore 575 001, India

2. College of Management & Commerce, Srinivas University, Mangalore, India,

3. Associate Professor, Brainware University, Kolkata, West Bengal 700125, India

Abstract

Who does not know that Twitter is an august social networking podium now? Here the folks around the globe are able to establish their viewpoints. Every day, almost 500 million tweets are established in twitter, and this volume contains 8TB data. The data that we derive from twitter is very much significant if we illustrate it, because we are able to derive significant news in the mode of sentiment analysis. From Twitter data, we get to know about the information and remarks of the augmentation of various product, novel fashion etc. Exploration of emotions, viewpoints, subjectivity and motive from a normal message or tweet for the application of drugs for the therapy of COVID-19, is the prime objective of this sentiment analysis. Now, comes clustering. It’s a method by which one can detect homogeneous substances, combine together and create a class or cluster. There was an initiative from of going on with a research from our end and the result of it showed that the implementation of clustering is able to get infirm and solid positive or negative tweets while getting clustered with outcomes of distinct dictionaries and present robust scaffolding on our prediction. The research analyzes the polarity calculation, applying VADER sentiment analysis for the application of drug for the therapy of COVID-19.

Publisher

Srinivas University

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3